C Diff Prevention

C Diff Prevention

604 bookmarks
Custom sorting
Therapeutic potential of probiotics in gut microbial homeostasis and Rheumatoid arthritis - PubMed
Therapeutic potential of probiotics in gut microbial homeostasis and Rheumatoid arthritis - PubMed
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and joint damage. Existing treatment options primarily focus on managing symptoms and slowing disease progression, often with side effects and limitations. The gut microbiome, a vast community of microorganisms p …
·pubmed.ncbi.nlm.nih.gov·
Therapeutic potential of probiotics in gut microbial homeostasis and Rheumatoid arthritis - PubMed
Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection
Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection
Clostridiodes difficile infection (CDI) continues to be one of the leading causes of healthcare-acquired diarrhea and infections, and recurrence is the biggest challenge in its management. As technology and research have led to a better understanding of the pathophysiology of C. difficile, we have come to appreciate the role that the gastrointestinal microbiota plays in infection onset and the prevention of recurrence. The gut microbiota is disrupted in those with CDI, which allows further propagation of the infection leading to recurrence, if the microbiota deficiency is unable to regrow itself. While antimicrobial therapy is necessary for treatment of any CDI, these therapeutics do not address the underlying disturbance of microbiota. Microbial remodulation therapies have been developed supplementing the microbiota deficiency that exists after the standard of care antimicrobial resulting in a reduction of recurrence. Fecal microbiota transplantation (FMT) was the initial attempt for this type of therapeutic and proved to be safe and effective, however never achieved FDA approval. In light of this, live biotherapeutic products (LBPs) were developed by pharmaceutical companies through a more standardized and regulated process. These products are safe and efficacious in reducing CDI recurrence when given after a standard of care antimicrobial, eventually leading to FDA approval of two products that can now be used widely in clinical practice.
·news.google.com·
Live biotherapeutic products: a capstone for prevention of recurrent Clostridiodes difficile infection
Primel launches new coating solution in battle against C. diff
Primel launches new coating solution in battle against C. diff
Primel, a provider of infection prevention solutions, has published the results of a new study proving its Active Hand Coating has achieved a high level of sporicidal activity (4 log 99.99 % efficacy).
·news.google.com·
Primel launches new coating solution in battle against C. diff
Inhibition of EGFR/ErbB does not protect against C. difficile toxin B - PubMed
Inhibition of EGFR/ErbB does not protect against C. difficile toxin B - PubMed
Clostridioides difficile is a common cause of diarrhea and mortality, especially in immunosuppressed and hospitalized patients. C. difficile is a toxin-mediated disease, but the host cell receptors for C. difficile toxin B (TcdB) have only recently been revealed. Emerging data s …
·pubmed.ncbi.nlm.nih.gov·
Inhibition of EGFR/ErbB does not protect against C. difficile toxin B - PubMed
Reducing Clostridioides difficile Infections in a Medical Intensive Care Unit: A Multimodal Quality Improvement Initiative - PubMed
Reducing Clostridioides difficile Infections in a Medical Intensive Care Unit: A Multimodal Quality Improvement Initiative - PubMed
We found clinically significant improvements in the rate of C. diff infection and PCR tests ordered as a result of implementing tailored interventions in a large medical intensive care unit. Other units should consider using robust quality improvement methods and tools to conduct similar initiatives …
·pubmed.ncbi.nlm.nih.gov·
Reducing Clostridioides difficile Infections in a Medical Intensive Care Unit: A Multimodal Quality Improvement Initiative - PubMed
Reducing Clostridioides difficile Infections in a Medical Intensive Care Unit: A Multimodal Quality Improvement Initiative - PubMed
Reducing Clostridioides difficile Infections in a Medical Intensive Care Unit: A Multimodal Quality Improvement Initiative - PubMed
We found clinically significant improvements in the rate of C. diff infection and PCR tests ordered as a result of implementing tailored interventions in a large medical intensive care unit. Other units should consider using robust quality improvement methods and tools to conduct similar initiatives …
·pubmed.ncbi.nlm.nih.gov·
Reducing Clostridioides difficile Infections in a Medical Intensive Care Unit: A Multimodal Quality Improvement Initiative - PubMed
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes - PubMed
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes - PubMed
Repeated exposure to antibiotics and changes in the diet and environment shift the gut microbial diversity and composition, making the host susceptible to pathogenic infection. The emergence and ongoing spread of AMR pathogens is a challenging public health issue. Recent evidence showed that probiot …
·pubmed.ncbi.nlm.nih.gov·
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes - PubMed
Comparative prebiotic potential of galacto- and fructo-oligosaccharides, native inulin, and acacia gum in Kenyan infant gut microbiota during iron supplementation - PubMed
Comparative prebiotic potential of galacto- and fructo-oligosaccharides, native inulin, and acacia gum in Kenyan infant gut microbiota during iron supplementation - PubMed
Iron fortification to prevent anemia in African infants increases colonic iron levels, favoring the growth of enteropathogens. The use of prebiotics may be an effective strategy to reduce these detrimental effects. Using the African infant PolyFermS gut model, we compared the effect of the prebiotic …
·pubmed.ncbi.nlm.nih.gov·
Comparative prebiotic potential of galacto- and fructo-oligosaccharides, native inulin, and acacia gum in Kenyan infant gut microbiota during iron supplementation - PubMed
Secondary prophylaxis for Clostridioides difficile infection for patients on non- Clostridioides difficile antibiotics: A retrospective cohort study - PubMed
Secondary prophylaxis for Clostridioides difficile infection for patients on non- Clostridioides difficile antibiotics: A retrospective cohort study - PubMed
Secondary prophylaxis with CDI antibiotics appears to be associated with a reduced risk of recurrence in patients with previous non-severe CDI episode. Further studies are needed to confirm this finding.
·pubmed.ncbi.nlm.nih.gov·
Secondary prophylaxis for Clostridioides difficile infection for patients on non- Clostridioides difficile antibiotics: A retrospective cohort study - PubMed
Assessing the stability and sporicidal efficacy of oxidising disinfectants - PubMed
Assessing the stability and sporicidal efficacy of oxidising disinfectants - PubMed
The role of the healthcare environment in the transmission of clinical pathogens is well established. We investigated the chemical stability and sporicidal efficacy of oxidising disinfectant products in the presence of simulated clean and medical dirty conditions. Performance of chlorine-releasing a …
·pubmed.ncbi.nlm.nih.gov·
Assessing the stability and sporicidal efficacy of oxidising disinfectants - PubMed
Hospital Acquired Infections and C. diff. Is My Hospital Safe?
Hospital Acquired Infections and C. diff. Is My Hospital Safe?
There isn’t a hospital in the country that isn’t battling against C. diff. infection. We are not winning the war against this crafty and cunning ...
·gastroendonews.com·
Hospital Acquired Infections and C. diff. Is My Hospital Safe?
CDC Strategies Tested for Preventing Hospital-Onset C difficile
CDC Strategies Tested for Preventing Hospital-Onset C difficile
Incidence of hospital-onset Clostridioides difficile infection differed between hospitals that implemented the CDC prevention strategies and those that did not, but not necessarily because of the strategies.
·news.google.com·
CDC Strategies Tested for Preventing Hospital-Onset C difficile
Antimicrobial effects of cannabidiol on select agriculturally important Clostridia - PubMed
Antimicrobial effects of cannabidiol on select agriculturally important Clostridia - PubMed
Amino acid-fermenting Clostridia have undesirable effects in agricultural systems, which can be mitigated by antibiotics, but resistance necessitates alternatives. Here, we demonstrate the efficacy of cannabidiol on growth and ammonia inhibition of five agriculturally relevant Clostridia: Clostridiu …
·pubmed.ncbi.nlm.nih.gov·
Antimicrobial effects of cannabidiol on select agriculturally important Clostridia - PubMed
CDC's Hospital-Onset Clostridioides difficile Prevention Framework in a Regional Hospital Network - PubMed
CDC's Hospital-Onset Clostridioides difficile Prevention Framework in a Regional Hospital Network - PubMed
In this quality improvement study of a regional hospital network, implementation of the Framework was not temporally associated with declining HO-CDI incidence. Further study of the effectiveness of multimodal prevention measures for controlling HO-CDI is warranted.
·pubmed.ncbi.nlm.nih.gov·
CDC's Hospital-Onset Clostridioides difficile Prevention Framework in a Regional Hospital Network - PubMed
Live Biotherapeutic Products for the Prevention of Recurrent Clostridioides difficile Infection - PubMed
Live Biotherapeutic Products for the Prevention of Recurrent Clostridioides difficile Infection - PubMed
Live biotherapeutic products provide a safe and effective option for the prevention of rCDI and represent an improvement over conventional FMT. Additional studies are needed to further determine their place in therapy relative to bezlotoxumab and in the setting of immunosuppression and inflammatory …
·pubmed.ncbi.nlm.nih.gov·
Live Biotherapeutic Products for the Prevention of Recurrent Clostridioides difficile Infection - PubMed
Infection Control Measure Performance in Long-Term Care Hospitals and Their Relationship to Joint Commission Accreditation - PubMed
Infection Control Measure Performance in Long-Term Care Hospitals and Their Relationship to Joint Commission Accreditation - PubMed
Although this study was not designed to establish causality, positive associations were observed between Joint Commission accreditation and CLABSI and CAUTI measures, and Joint Commission-accredited LTCHs attained more consistent high performance over the four-year study period for all three measure …
·pubmed.ncbi.nlm.nih.gov·
Infection Control Measure Performance in Long-Term Care Hospitals and Their Relationship to Joint Commission Accreditation - PubMed
Impact of a syndrome-based stewardship intervention on antipseudomonal beta-lactam use, antimicrobial resistance, C. difficile rates, and cost in a safety-net community hospital - PubMed
Impact of a syndrome-based stewardship intervention on antipseudomonal beta-lactam use, antimicrobial resistance, C. difficile rates, and cost in a safety-net community hospital - PubMed
Broad-spectrum antimicrobials are commonly used without indication and contribute to antimicrobial resistance (AMR). We implemented a syndrome-based stewardship intervention in a community hospital that targeted common infectious syndromes and antipseudomonal beta-lactam (APBL) use. Our intervention …
·pubmed.ncbi.nlm.nih.gov·
Impact of a syndrome-based stewardship intervention on antipseudomonal beta-lactam use, antimicrobial resistance, C. difficile rates, and cost in a safety-net community hospital - PubMed
The Role of Probiotics in the Prevention of Clostridioides difficile Infection in Patients with Chronic Kidney Disease - PubMed
The Role of Probiotics in the Prevention of Clostridioides difficile Infection in Patients with Chronic Kidney Disease - PubMed
In patients suffering from chronic kidney disease (CKD), substantial unfavourable alterations in the intestinal microbiota composition, i.e., dysbiosis, have been noted. The main causes of such dysbiosis among others are insufficient dietary fibre content in the diet, fluid restrictions, medications …
·pubmed.ncbi.nlm.nih.gov·
The Role of Probiotics in the Prevention of Clostridioides difficile Infection in Patients with Chronic Kidney Disease - PubMed
Effect of Virtual Reality Simulation Versus Traditional Education on Rates of Clostridium difficile Infection: An Experimental Cluster Randomized Controlled Trial and Return on Investment Analysis - PubMed
Effect of Virtual Reality Simulation Versus Traditional Education on Rates of Clostridium difficile Infection: An Experimental Cluster Randomized Controlled Trial and Return on Investment Analysis - PubMed
Findings showed that VRS was an effective instructional method. [J Contin Educ Nurs. 202x;5x(x):xx-xx.].
·pubmed.ncbi.nlm.nih.gov·
Effect of Virtual Reality Simulation Versus Traditional Education on Rates of Clostridium difficile Infection: An Experimental Cluster Randomized Controlled Trial and Return on Investment Analysis - PubMed